Donate Help Contact The AHA Sign In Home
American Heart Association
Arteriosclerosis, Thrombosis, and Vascular Biology
Search: search_blue_button Advanced Search
Arteriosclerosis, Thrombosis, and Vascular Biology. 2005;25:2522-2527
Published online before print October 6, 2005, doi: 10.1161/01.ATV.0000189298.62240.5d
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Data Supplement
Right arrow All Versions of this Article:
25/12/2522    most recent
01.ATV.0000189298.62240.5dv1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Tesse, A.
Right arrow Articles by Andriantsitohaina, R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Tesse, A.
Right arrow Articles by Andriantsitohaina, R.
(Arteriosclerosis, Thrombosis, and Vascular Biology. 2005;25:2522.)
© 2005 American Heart Association, Inc.


Vascular Biology

Upregulation of Proinflammatory Proteins Through NF-{kappa}B Pathway by Shed Membrane Microparticles Results in Vascular Hyporeactivity

Angela Tesse; M. Carmen Martínez; Bénédicte Hugel; Karel Chalupsky; Christian D. Muller; Ferhat Meziani; Delia Mitolo-Chieppa; Jean-Marie Freyssinet; Ramaroson Andriantsitohaina

From Pharmacologie et Physico-Chimie des Interactions Cellulaires et Moléculaires (A.T., K.C., C.M., F.M., R.A.), UMR CNRS 7034, Illkirch, France; Dipartimento di Farmacologia e Fisiologia Umana (A.T., D.M.-C.), Università di Bari, Italia; Institut d’Hématologie et d’Immunologie (M.C.M., B.H., J.-M.F.), Université Louis Pasteur, Strasbourg, France & Unité 143 INSERM, Le Kremlin-Bicêtre, France

Correspondence to Dr Ramaroson Andriantsitohaina, UMR CNRS 7081, Faculté de Pharmacie, 74, route du Rhin, 67401 Illkirch, France. E-mail ramaroson.andriantsitohaina{at}pharma.u-strasbg.fr

Objective— Microparticles are membrane vesicles with procoagulant and proinflammatory properties released during cell activation, including apoptosis. The present study was designed in dissecting the effects evoked by microparticles on vascular reactivity.

Methods and Results— Microparticles from either apoptotic T lymphocytic cells or from plasma of diabetic patients with vascular complications induced vascular hyporeactivity in response to vasoconstrictor agents in mouse aorta. Hyporeactivity was reversed by nitric oxide (NO) synthase plus cyclooxygenase-2 inhibitors, and associated with an increased production of vasodilatory products such as NO and prostacyclin. Microparticles induced an upregulation of proinflammatory protein expressions, inducible NO-synthase and cyclooxygenase-2, mainly in the medial layer of the vessels as evidenced by immunochemical staining. In addition, microparticles evoke NF-{kappa}B activation probably through the interaction with the Fas/Fas Ligand pathway. Finally, in vivo treatment of mice with lymphocyte-derived MPs induces vascular hyporeactivity, which was reversed by the combination of NO and cyclooxygenase-2 inhibitors.

Conclusion— These data provide a rationale to explain the paracrine role of microparticles as vectors of transcellular exchange of message in promoting vascular dysfunction during inflammatory diseases.

Microparticles are membrane vesicles with procoagulant and proinflammatory properties released during cell activation. T cell–derived microparticles induce in vivo and in vitro vascular hyporeactivity associated with NO and prostacyclin production. Microparticles induce inducible NO synthase and cyclooxygenase-2, and evoke NF-{kappa}B activation through Fas/FasLigand pathway. Microparticles promote vascular dysfunction during inflammatory diseases.


Key Words: Fas/Fas Ligand • microvesicles • proinflammatory proteins • vascular dysfunction • vasoactivity




This article has been cited by other articles:


Home page
J. Immunol.Home page
H. A. Mostefai, A. Agouni, N. Carusio, M. L. Mastronardi, C. Heymes, D. Henrion, R. Andriantsitohaina, and M. C. Martinez
Phosphatidylinositol 3-Kinase and Xanthine Oxidase Regulate Nitric Oxide and Reactive Oxygen Species Productions by Apoptotic Lymphocyte Microparticles in Endothelial Cells
J. Immunol., April 1, 2008; 180(7): 5028 - 5035.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
A. Tesse, G. Al-Massarani, R. Wangensteen, S. Reitenbach, M. C. Martinez, and R. Andriantsitohaina
Rosiglitazone, a Peroxisome Proliferator-Activated Receptor-{gamma} Agonist, Prevents Microparticle-Induced Vascular Hyporeactivity through the Regulation of Proinflammatory Proteins
J. Pharmacol. Exp. Ther., February 1, 2008; 324(2): 539 - 547.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
C. Yang, B. R. Mwaikambo, T. Zhu, C. Gagnon, J. Lafleur, S. Seshadri, P. Lachapelle, J.-C. Lavoie, S. Chemtob, and P. Hardy
Lymphocytic microparticles inhibit angiogenesis by stimulating oxidative stress and negatively regulating VEGF-induced pathways
Am J Physiol Regulatory Integrative Comp Physiol, February 1, 2008; 294(2): R467 - R476.
[Abstract] [Full Text] [PDF]


Home page
FASEB J.Home page
A. Agouni, H. A. Mostefai, C. Porro, N. Carusio, J. Favre, V. Richard, D. Henrion, M. C. Martinez, and R. Andriantsitohaina
Sonic hedgehog carried by microparticles corrects endothelial injury through nitric oxide release
FASEB J, September 1, 2007; 21(11): 2735 - 2741.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
A. Tesse, F. Meziani, E. David, N. Carusio, H. Kremer, F. Schneider, and R. Andriantsitohaina
Microparticles from preeclamptic women induce vascular hyporeactivity in vessels from pregnant mice through an overproduction of NO
Am J Physiol Heart Circ Physiol, July 1, 2007; 293(1): H520 - H525.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
O. Morel, F. Toti, B. Hugel, B. Bakouboula, L. Camoin-Jau, F. Dignat-George, and J.-M. Freyssinet
Procoagulant Microparticles: Disrupting the Vascular Homeostasis Equation?
Arterioscler. Thromb. Vasc. Biol., December 1, 2006; 26(12): 2594 - 2604.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
F. Meziani, A. Tesse, E. David, M. C. Martinez, R. Wangesteen, F. Schneider, and R. Andriantsitohaina
Shed Membrane Particles from Preeclamptic Women Generate Vascular Wall Inflammation and Blunt Vascular Contractility
Am. J. Pathol., October 1, 2006; 169(4): 1473 - 1483.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
C. M. Boulanger, N. Amabile, and A. Tedgui
Circulating Microparticles: A Potential Prognostic Marker for Atherosclerotic Vascular Disease
Hypertension, August 1, 2006; 48(2): 180 - 186.
[Full Text] [PDF]